肝脏 ›› 2021, Vol. 26 ›› Issue (7): 788-791.

• 其他肝病 • 上一篇    下一篇

巨大肝血管瘤患者临床特征及不同介入栓塞材料的价值观察

张均维, 黄旭东, 蔡弟, 王桂浩   

  1. 232001 安徽淮南 淮南东方医院集团总医院放射介入科
  • 收稿日期:2020-11-10 出版日期:2021-07-31 发布日期:2021-09-02
  • 通讯作者: 张均维,Email:h789645@126.com
  • 基金资助:
    安徽省重点研究与开发项目(1704a0802150)

The clinical characteristics of giant hepatic hemangioma and observation of the application value of different interventional embolization materials

ZHANG Jun-wei, HUANG Xu-dong, CAI Di, WANG Gui-hao   

  1. Department of interventional radiology, General Hospital of Huainan Oriental Hospital Group, Huainan 232001, China
  • Received:2020-11-10 Online:2021-07-31 Published:2021-09-02
  • Contact: ZHANG Jun-wei,Email:h789645@126.com

摘要: 目的 研究巨大肝血管瘤患者临床特征及不同介入栓塞材料的应用价值。方法 收集2017年3月至2020年3月84例巨大肝血管瘤患者临床资料,所有患者均接受彩色多普勒血流显像(CDFI)检查和介入栓塞治疗,记录CDFI血流动力学特征。根据介入栓塞材料不同,将84例患者分为观察组(n=48)和对照组(n=36),其中观察组采用平阳霉素碘化油栓塞治疗,对照组采用博莱霉素碘化油栓塞治疗。比较两组治疗效果,记录不同血流动力学特征患者临床疗效。结果 CDFI检查结果显示84例患者中23例为富血供型,占27.38%;47例为少血供型,占55.95%;乏血供型14例,占16.67%。治疗3个月后观察组瘤体直径显著低于对照组,差异有统计学意义(P<0.05)。两组患者住院时间、住院费用及不良反应发生率比较,差异均无统计学意义(P>0.05)。富血供组患者整体疗效显著优于少血供组和乏血供组,差异均有统计学意义(P<0.05)。受试者操作特征曲线(ROC)分析结果显示,肝血管瘤直径判断平阳霉素碘化油栓塞治疗效果的AUC为0.743(95%CI=0.559~0.657,SE=0.079,P=0.028),敏感度为0.833,特异度为0.583,截断值为13.21 cm。结论 巨大肝血管瘤患者以富血供型和少血供型为主,平阳霉素碘化油栓塞材料治疗巨大肝血管瘤的疗效优于博莱霉素,尤其是对于富血供和瘤体直径小于13.21 cm的患者,疗效显著。

关键词: 巨大肝血管瘤, 病理特征, 栓塞材料, 临床疗效

Abstract: Objective To study the clinical characteristics of patients with giant hepatic hemangioma and observation of the application value of different interventional embolization materials. Methods The clinical data of 84 patients with giant hepatic hemangioma from March 2017 to March 2020 were collected, all patients received color Doppler Flow Imaging (CDFI) examination and interventional embolization, the CDFI hemodynamic characteristics were recorded.84 patients were divided into observation group (n=48) and control group (n=36) according to the different embolization materials. The observation group was treated with pingyangmycin iodized oil embolization, and the control group was treated with bleomycin iodized oil embolization. The treatment effects of the two groups were compared, and the clinical effects of patients with different hemodynamic characteristics were recorded. Results The results of CDFI examination showed that there were 23 cases of high blood supply in the 84 patients, which accounting for 27.38%, the 47 cases of low blood supply type, which accounting for 55.95%, 14 cases of poor blood supply, which accounting for 16.67%. The tumor diameter in the observation group at 3 months after treatment was significantly lower than that in the control group, the difference was statistically significant (P<0.05). There was no statistically significant difference in hospitalization time, hospitalization expenses and incidence of adverse reactions between the two groups (P>0.05). The overall curative effect of patients in the high blood supply group was significantly better than that of the low blood supply group and the poor blood supply group, the difference was statistically significant (P<0.05). The results of receiver operator characteristic (ROC) analysis showed that the AUC of diameter of hepatic hemangioma for judging the effect of pingyangmycin iodized oil embolization was 0.743 (95% CI=0.559~0.657, SE=0.079, P=0.028), the sensitivity was 0.833, the specificity was 0.583, and the cutoff value was 13.21 cm. Conclusion The patients with giant hepatic hemangioma are mainly of high blood supply and low blood supply. The pingyangmycin iodized oil embolization material is better than bleomycin in the treatment of giant hepatic hemangioma, especially for the high blood supply and the tumor diameter less than 13.21 cm, and the effect was significant.

Key words: Giant hepatic hemangioma, Pathological features, Embolic material, Clinical efficacy